Brief: Summit Therapeutics To Host Esmo Data Update & Third Quarter Earnings Call On October 20, 2025
15/10/2025 12:16
Oct 15 (Reuters) - Summit Therapeutics Inc SMMT.O: SUMMIT THERAPEUTICS TO HOST ESMO DATA UPDATE & THIRD QUARTER EARNINGS CALL ON OCTOBER 20, 2025 Source text: ID:nBww37Rga Further company coverage: SMMT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Summit Therapeutics
See all newsBrief: Akeso Announces Summit Therapeutics And Ecog-Acrin Cancer Research Group Enter Into Phase Ii/Iii Clinical Trial Collaboration To Evaluate Ivonescimab In First-Line Biliary Tract Cancer
Factbox: Major drugmakers turn to China for licensing deals
Brief: Summit Therapeutics Announces Opening Of Global Phase Ii Study Of Ivonescimab-Based Regimens In Advanced Clear Cell Renal Cell Carcinoma
Factbox: Major drugmakers turn to China for licensing deals
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination (updated)